Search results
Author(s):
Blandine Mondésert
,
Pier D Lambiase
,
Lluis Mont
,
et al
Start date:
Oct 23, 2024
This session covers the latest data on transvenous and subcutaneous ICD devices, focusing on shared decision-making and their practical applications in preventing sudden cardiac death. Moderated by Dr Blandine Mondésert (Montreal Heart Institute and University of Montreal, CA) and Dr Ulrika Birgersdotter-Green (University of California San Diego, US), this webinar delves into the long-term…
View more
Author(s):
Christophe Leclercq
Added:
2 months ago
EHRA 2025 - Outcomes from cardiac resynchronization therapy (CRT) with MultiPoint pacing (MPP) to treat patients who are not responding to standard CRT show that MPP does not improve the conversion rate of non-responders to responders compared to standard CRT; however, a reduction in HF hospitalisation was seen in the group receiving MPP.Prof Christophe Leclercq (Centre Hospitalier Universitaire…
View more
Author(s):
Akriti Naraen
,
Dileep Duvva
,
Archana Rao
Added:
1 year ago
LBBAP in Heart Failure
Author(s):
Juan Carlos Diaz
,
Mauricio Duque
,
Julian Aristizabal
,
et al
Added:
1 year ago
Article
Author(s):
Gi-Byoung Nam
,
Min Soo Cho
Added:
9 months ago
ESC Congress 2024 — Edoxaban monotherapy significantly improves outcomes in high-risk patients with CAD and atrial fibrillation.Investigators, Dr Gi-Byoung Nam (Ulsan University Hospital, Ulsan, SK) and Dr Min Soo Cho (Asan Medical Center, Seoul, SK) join us to discuss the key findings from the EPIC-CAD trial (NCT03718559).This Korean multi-centre, open-labelled, randomised controlled study…
View more
Author(s):
Dipak Kotecha
Added:
9 months ago
ESC Congress 2024 — Improved patient-level adherence to guideline recommendations on heart rhythm control through healthcare professional education in patients with atrial fibrillation.Investigator, Dr Dipak Kotecha (University of Birmingham, UK) joins us in London to share key findings from the STEEER-AF study (NCT04396418).This prospective, cluster-randomized international study compared two…
View more
Author(s):
Added:
2 months ago
EHRA 2025 - Long-term insights from pacemaker implantation after transcatheter aortic valve implantation (TAVI) show patients receiving pacemaker therapy within 30 days after TAVI had a significantly worse prognosis compared to patients with no pacemaker therapy in regards to all-cause death and CV death at one, five and ten year follow-ups.Prof Patrick Badertscher (University Hospital Basel,…
View more
Added:
3 months ago
Source:
Arrhythmia Academy
AUTHOR: David RamseyLeading cardiovascular societies have unveiled an updated appropriate use criteria (AUC) document redefining clinical decision-making for cardiac implantable devices. The practice guideline entitled "ACC/AHA/ASE/HFSA/HRS/SCAI/SCCT/SCMR 2025 Appropriate Use Criteria for Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy, and Pacing" was published online…
View more
Paola Fioretto
Author